The use of neoadjuvant immunotherapy for patients with head and neck squamous cell carcinoma has nearly doubled since 2013 in the US, but disparities in access exist.
Medscape Medical News
Source link : https://www.medscape.com/viewarticle/pre-op-immunotherapy-head-and-neck-cancer-rising-2025a1000ter?src=rss
Author :
Publish date : 2025-10-28 19:38:00
Copyright for syndicated content belongs to the linked Source.
